Profile data is unavailable for this security.
About the company
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
- Revenue in USD (TTM)422.65m
- Net income in USD-9.12m
- Incorporated2022
- Employees1.60k
- LocationArtivion Inc1655 Roberts Boulevard N WKENNESAW 30144United StatesUSA
- Phone+1 (770) 419-3355
- Fax+1 (770) 426-0031
- Websitehttps://artivion.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp | 1.37bn | 47.06m | 1.29bn | 3.90k | 27.59 | -- | 10.67 | 0.9416 | 1.52 | 1.52 | 44.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 54.08 | 55.56 | 3.42 | 3.78 | -- | 3.24 | -- | -- | 5.18 | 9.77 | -64.47 | 37.66 | -- | -5.59 |
| Adapthealth Corp | 3.26bn | 75.81m | 1.38bn | 10.50k | 18.37 | 0.8544 | 2.90 | 0.4243 | 0.5553 | 0.5553 | 23.90 | 11.94 | 0.7354 | 17.20 | 8.33 | 310,020.30 | 1.96 | -2.81 | 2.28 | -3.17 | 25.32 | 19.63 | 2.67 | -4.19 | 0.8584 | 2.30 | 0.5253 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
| Procept Biorobotics Corp | 299.91m | -84.58m | 1.55bn | 756.00 | -- | 4.08 | -- | 5.18 | -1.54 | -1.54 | 5.45 | 6.81 | 0.6772 | 1.81 | 3.91 | 396,702.40 | -19.10 | -26.94 | -21.74 | -29.81 | 64.55 | 54.37 | -28.20 | -83.14 | 7.20 | -- | 0.1194 | -- | 64.84 | 105.21 | 13.68 | -- | -10.34 | -- |
| Pulse Biosciences Inc | 86.00k | -74.73m | 1.56bn | 75.00 | -- | 16.82 | -- | 18,131.77 | -1.14 | -1.14 | 0.0013 | 1.37 | 0.0009 | -- | -- | 1,146.67 | -74.06 | -83.75 | -80.63 | -94.40 | -224.42 | -- | -86,898.84 | -12,644.52 | 10.01 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.57bn | 330.00 | -- | 8.44 | -- | 21.15 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Quidelortho Corp | 2.73bn | -1.13bn | 1.60bn | 6.60k | -- | 0.8341 | -- | 0.5867 | -16.66 | -16.66 | 40.27 | 28.27 | 0.4478 | 2.62 | 7.46 | -- | -18.56 | -6.45 | -22.13 | -7.39 | 46.67 | 53.89 | -41.45 | -14.40 | 0.9002 | 0.6757 | 0.5798 | -- | -1.89 | 10.44 | 44.84 | -- | -- | -- |
| AtriCure Inc | 518.31m | -28.77m | 1.62bn | 1.30k | -- | 3.41 | -- | 3.13 | -0.608 | -0.608 | 10.90 | 9.59 | 0.829 | 1.68 | 8.79 | 398,696.20 | -4.60 | -3.84 | -5.24 | -4.25 | 74.87 | 74.53 | -5.55 | -7.13 | 2.85 | -17.96 | 0.1252 | -- | 16.55 | 15.05 | -46.85 | -- | 14.00 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.64bn | 3.60k | 844.32 | 1.33 | 20.01 | 1.38 | 0.0432 | 0.0432 | 25.70 | 27.45 | 0.5786 | 7.19 | 5.01 | -- | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.80 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | -- | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| AxoGen Inc | 214.71m | -2.10m | 1.67bn | 451.00 | -- | 12.69 | 343.24 | 7.76 | -0.0486 | -0.0486 | 4.56 | 2.62 | 1.05 | 1.55 | 7.75 | 476,073.20 | -1.03 | -11.36 | -1.17 | -13.05 | 74.76 | 78.42 | -0.9767 | -15.37 | 2.64 | 0.6493 | 0.2852 | -- | 17.81 | 11.91 | 54.12 | -- | -2.84 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.71bn | 1.33k | 12.02 | 2.19 | 10.71 | 1.87 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Artivion Inc | 422.65m | -9.12m | 1.75bn | 1.60k | -- | 3.95 | 126.38 | 4.14 | -0.242 | -0.242 | 9.48 | 9.26 | 0.509 | 1.72 | 5.16 | 264,153.80 | -1.10 | -2.47 | -1.29 | -2.66 | 64.50 | 65.02 | -2.16 | -5.89 | 2.88 | 1.29 | 0.3324 | -- | 9.75 | 7.06 | 56.37 | -- | 6.75 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 1.76bn | 699.00 | -- | 6.77 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
| UFP Technologies Inc | 597.95m | 67.12m | 1.90bn | 4.15k | 28.54 | 4.69 | 22.06 | 3.17 | 8.61 | 8.61 | 76.71 | 52.37 | 0.9261 | 4.89 | 6.86 | 144,223.80 | 10.40 | 10.12 | 11.87 | 11.53 | 28.51 | 27.07 | 11.23 | 10.64 | 1.36 | 8.39 | 0.2657 | 0.00 | 26.08 | 20.52 | 31.29 | 24.46 | 10.82 | -- |
| Alphatec Holdings Inc | 728.02m | -154.96m | 1.98bn | 867.00 | -- | 173.41 | -- | 2.73 | -1.05 | -1.05 | 4.91 | 0.2351 | 0.9497 | 1.28 | 7.90 | 839,700.10 | -20.21 | -27.43 | -26.81 | -34.69 | 69.23 | 66.99 | -21.29 | -39.40 | 1.24 | -1.86 | 0.941 | -- | 26.81 | 40.07 | 13.14 | -- | 48.19 | -- |
| LeMaitre Vascular Inc | 240.87m | 53.34m | 1.99bn | 651.00 | 38.41 | 5.25 | 31.25 | 8.26 | 2.28 | 2.28 | 10.35 | 16.71 | 0.494 | 1.03 | 7.45 | 369,993.80 | 10.94 | 9.09 | 11.69 | 9.89 | 70.97 | 66.24 | 22.14 | 16.64 | 11.45 | -- | 0.3077 | 38.38 | 13.63 | 13.40 | 46.28 | 19.68 | 13.11 | 15.91 |
| Establishment Labs Holdings Inc | 190.97m | -82.98m | 2.17bn | 1.02k | -- | 132.47 | -- | 11.35 | -2.84 | -2.84 | 6.53 | 0.5632 | 0.6145 | 0.769 | 2.75 | 187,596.30 | -26.70 | -31.53 | -33.25 | -39.32 | 68.74 | 65.46 | -43.45 | -45.09 | 2.10 | -1.72 | 0.9377 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
Data as of Feb 13 2026. Currency figures normalised to Artivion Inc's reporting currency: US Dollar USD
49.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 5.91m | 12.47% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 2.84m | 5.99% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.83m | 5.97% |
| Nomura Investment Management Business Trustas of 30 Sep 2025 | 2.48m | 5.24% |
| Perceptive Advisors LLCas of 30 Sep 2025 | 2.02m | 4.26% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 1.83m | 3.87% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.58m | 3.35% |
| Wellington Management Co. LLPas of 30 Sep 2025 | 1.35m | 2.84% |
| Juniper Investment Co. LLCas of 30 Sep 2025 | 1.33m | 2.82% |
| Weatherbie Capital LLCas of 30 Sep 2025 | 1.17m | 2.48% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
